---
title: "Nasdaq Approves Listing for Canary's Staked Injective ETF"
description: "The proposed INJC fund plans to stake at least 90% of its INJ tokens while levying a 1.10% sponsor fee."
url: https://basisdesk.news/news/nasdaq-approves-listing-canary-staked-injective-etf
published: 2026-11-04T20:53:31.177Z
modified: 2026-11-04T20:53:31.177Z
section: Institutions & ETFs
author: Basis Desk Newsroom (AI-generated, source-verified)
sentiment: bullish
tickers: [INJ]
tags: [nasdaq, injective, etf, staking, canary]
license: Quote with attribution to Basis Desk (basisdesk.news). Not financial advice.
---

# Nasdaq Approves Listing for Canary's Staked Injective ETF

The proposed INJC fund plans to stake at least 90% of its INJ tokens while levying a 1.10% sponsor fee.

## At a glance

- **What happened:** Nasdaq approved the listing of Canary's staked Injective ETF, trading under ticker INJC.
- **Why it matters:** The vehicle introduces an exchange-traded structure committing at least 90% of fund INJ assets to network staking.
- **Who is affected:** Canary, Injective ecosystem participants, and Nasdaq market participants.
- **What's next:** No next step announced.
- **Status:** announced
- **Primary source:** [Nasdaq Approves Listing of Canary’s Staked Injective ETF](https://thedefiant.io/news/tokens/nasdaq-approves-listing-of-canary-s-staked-injective-etf) — thedefiant.io

## Key points

- Nasdaq approved the listing of Canary's staked Injective exchange-traded fund [1].
- The proposed INJC fund is designed to stake at least 90% of its underlying INJ holdings [1].
- Canary plans to levy a 1.10% annual sponsor fee for managing the vehicle [1].

## Editorial remark

- **Context:** Asset managers have sought to introduce exchange-traded staking vehicles to capture protocol yields on underlying Proof-of-Stake assets alongside standard exchange-traded exposure.
- **Impact:** Injective and Canary secure listing clearance on Nasdaq for the INJC vehicle, establishing operational parameters with a 90% staking requirement and a 1.10% management fee.
- **Watch:** Canary's operational filings and exchange announcements regarding an official launch date and secondary market trading schedule for INJC.

Nasdaq approved the listing of Canary's staked Injective exchange-traded fund, according to reporting from The Defiant on Nov. 4 [1]. The exchange operator cleared the listing application for the vehicle, which is designated under the ticker INJC [1].

Under the proposed fund architecture, INJC is slated to stake at least 90% of its native $INJ holdings [1]. In exchange for managing the vehicle and staking operations, the fund will charge investors an annual sponsor fee of 1.10% [1]. The product focuses directly on the Injective Protocol network, utilizing staking mechanisms to generate protocol yield directly alongside fund management [1].

## Exchange Expansion

The move marks an expansion of exchange listings tied to staking-focused digital asset funds, bringing alternative Layer-1 protocol staking into structured exchange products [1]. Staking vehicles typically require distinct operational designs compared to traditional spot exchange-traded products, particularly due to the mechanics of locking underlying tokens and managing validator distributions on networks like Injective [1].

Nasdaq did not disclose an official launch date or a timeline for secondary market trading in the announcement details [1]. Canary has not detailed further custody or specific staking validator allocations for the INJC vehicle [1].

## Sources

1. [Nasdaq Approves Listing of Canary’s Staked Injective ETF](https://thedefiant.io/news/tokens/nasdaq-approves-listing-of-canary-s-staked-injective-etf) — thedefiant.io, 2026-11-04

---
Basis Desk Newsroom · AI-generated, source-verified · https://basisdesk.news/about/how-we-use-ai